Testing effectiveness (Phase 2)Study completedNCT00212875
What this trial is testing
Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.
Who this might be right for
Chronic Kidney DiseaseAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 267